Recent 8-K filings for PRA

• June 26, 2026, 12:08 PM ET M&A materiality 1.00 neutral item 1.02item 2.01item 3.01item 3.03item 5.01item 5.02item 5.03item 9.01 ◈ executive_change ×4

  ProAssurance acquired by The Doctors Company for $25.00 per share in all-cash merger

  Merger closed June 26, 2026; each PRA share converted to $25.00 cash.

• June 23, 2026, 5:21 PM ET M&A materiality 0.85 neutral item 8.01

  ProAssurance gets all regulatory approvals for merger with The Doctors Company; closing June 26

  All insurance regulatory approvals received as of June 23, 2026.

• May 5, 2026, 7:59 PM ET earnings materiality 0.65 neutral item 2.02item 9.01 ◈ Earnings Releases

  ProAssurance Q1 operating income $12.7M; merger with Doctors Company targets June 30 close

  Net income $8.5M ($0.16 diluted EPS); operating income $12.7M ($0.25 diluted EPS).

• February 23, 2026, 6:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  ProAssurance reports Q4 net income $33.4M ($0.64 EPS); merger update

  Q4 net income $33.4M ($0.64 diluted EPS); operating income $42.4M ($0.82 diluted EPS).

• November 4, 2025, 6:59 PM ET earnings materiality 0.75 neutral item 2.02item 7.01item 9.01

  ProAssurance Q3 net income $1.4M; merger with Doctors Co. pending regulatory approvals

  Q3 net income $1.4M ($0.03 diluted EPS); operating income $7.9M ($0.15 diluted EPS).

• August 5, 2025, 7:59 PM ET earnings materiality 0.70 positive item 2.02item 7.01item 9.01

  ProAssurance reports Q2 net income $21.9M ($0.42 EPS); merger with Doctors Co. on track

  Net income $21.9M ($0.42 diluted EPS); operating income $26.8M ($0.52 diluted EPS) for Q2 2025.

• June 24, 2025, 7:59 PM ET M&A materiality 0.80 positive item 5.07item 8.01item 9.01

  ProAssurance shareholders approve acquisition by The Doctors Company with over 99% vote in favor

  Stockholders voted 38,225,337 for, 363,050 against, 22,192 abstain; over 99% of votes cast in favor.

• May 6, 2025, 7:59 PM ET earnings materiality 0.70 neutral item 2.02item 7.01item 9.01

  ProAssurance Q1 net loss $5.8M ($0.11/sh), operating income $6.8M; The Doctors Company acquisition for $25/share

  Net loss of $5.8M ($0.11 diluted loss); operating income of $6.8M ($0.13 diluted share).

• March 20, 2025, 7:59 PM ET M&A materiality 1.00 positive item 1.01item 9.01

  ProAssurance to be acquired by The Doctors Company for $25.00 per share in cash

  Merger consideration of $25.00 cash per share; value to be paid to stockholders (excluding certain shares).

• March 19, 2025, 7:59 PM ET M&A materiality 0.90 positive item 8.01item 9.01

  ProAssurance to be acquired by The Doctors Company for $25/share cash, ~$1.3B

  Stockholders receive $25.00 per share in cash, a ~60% premium to March 18 close.

• February 24, 2025, 6:59 PM ET earnings materiality 0.65 positive item 2.02item 7.01item 9.01

  ProAssurance Q4 net income $16.2M ($0.31/diluted); full-year $52.7M ($1.03/diluted)

  Q4 2024 net income $16.2M ($0.31/diluted); operating income $18.3M ($0.36/diluted).

• November 7, 2024, 6:59 PM ET earnings materiality 0.70 positive item 2.02item 7.01item 9.01

  ProAssurance Q3 net income $16.4M; operating income $0.34/sh, combined ratio 99.5%

  Net income of $16.4M ($0.32 diluted EPS); operating income $17.3M ($0.34 diluted EPS).

• March 11, 2024, 7:59 PM ET earnings materiality 0.80 negative item 7.01item 9.01

  ProAssurance posts FY23 net loss of $38.6M; workers' comp combined ratio 121.5%

  FY23 non-GAAP operating loss $7.3M ($0.14/diluted share); Q4 operating loss $2.5M ($0.05/share).

• November 15, 2023, 6:59 PM ET earnings materiality 0.75 negative item 7.01item 9.01

  ProAssurance Q3 net loss $49.4M, $44M goodwill impairment, refinances $250M notes

  Net loss of $49.4M in Q3 2023 vs. $9.1M loss in Q3 2022; non-GAAP operating loss of $3.7M.

• November 8, 2023, 6:59 PM ET earnings materiality 0.70 negative item 2.02item 7.01item 9.01 ◈ Earnings Releases ×2

  ProAssurance reports Q3 net loss of $49.4M ($0.95/share); operating loss $3.7M

  Net loss of $49.4M ($0.95 diluted EPS); operating loss of $3.7M ($0.07).

• August 14, 2023, 7:59 PM ET earnings materiality 0.65 neutral item 7.01item 9.01

  ProAssurance Q2 net income $10.6M vs -$1.7M YoY; operating EPS $0.16 vs $0.30

  Q2 2023 net premiums earned $247.9M (flat YoY); total revenues $291.8M vs $255.8M.

• August 8, 2023, 7:59 PM ET earnings materiality 0.60 neutral item 2.02item 7.01item 9.01

  ProAssurance Q2 net income $10.6M ($0.20 EPS); investment income up 44%

  Operating income of $8.6M ($0.16 EPS) vs net income $10.6M ($0.20 diluted EPS).

• June 15, 2023, 7:59 PM ET earnings materiality 0.65 negative item 7.01item 9.01

  ProAssurance reports Q1 2023 net loss of $6.2M, combined ratio of 114.3% in investor presentation

  Q1 2023 net loss of $6.2M; non-GAAP operating loss of $8.1M ($0.15 diluted).

• May 30, 2023, 7:59 PM ET earnings materiality 0.65 negative item 2.02item 7.01item 9.01

  ProAssurance posts Q1 2023 net loss of $6.2M; diluted EPS -$0.11

  Net loss of $6.2M ($0.11 diluted loss); operating loss of $8.1M ($0.15 diluted loss).

• May 26, 2023, 7:59 PM ET dividend materiality 0.75 negative item 5.07item 7.01item 8.01item 9.01 ◈ Shareholder Votes ×4

  ProAssurance suspends quarterly cash dividend; will use share repurchases instead

  Board suspended quarterly cash dividend, citing current share trading price.

• March 3, 2023, 6:59 PM ET earnings materiality 0.60 neutral item 7.01item 9.01

  ProAssurance reports near-breakeven FY2022 net loss; Specialty P&C combined ratio 104.2%

  FY2022 net loss of $0.4M; non-GAAP operating income $24.5M ($0.45 diluted EPS).

• February 27, 2023, 6:59 PM ET earnings materiality 0.70 neutral item 2.02item 7.01item 9.01 ◈ Earnings Releases

  ProAssurance Q4 net income $13.9M ($0.26 EPS); full year gross premiums $1.1B (+15%)

  Net income $13.9M ($0.26 diluted EPS); operating income $3.5M ($0.06 diluted EPS) for Q4 2022.

• November 14, 2022, 6:59 PM ET earnings materiality 0.70 negative item 7.01item 9.01

  ProAssurance Q3 net loss of $9.1M vs year-ago profit; revenue down 12%

  Q3 2022 net loss of $9.1M ($0.17 per share) vs net income of $12.2M in Q3 2021.

• November 8, 2022, 6:59 PM ET earnings materiality 0.70 negative item 2.02item 7.01item 9.01 ◈ Earnings Releases

  ProAssurance reports Q3 net loss of $9.1M; operating loss $0.06 per share

  Net loss of $9.1M ($0.17 diluted EPS); operating loss of $3.0M ($0.06 per share).

• September 9, 2022, 7:59 PM ET other material materiality 0.65 negative item 7.01item 9.01

  ProAssurance reports Q2 2022 net loss of $1.7M, down from $92.1M net income in prior year; combined ratio 100.8%

  Q2 2022 net loss $1.7M versus net income $92.1M in Q2 2021; non-GAAP operating income fell to $16.3M from $26.6M.

• August 8, 2022, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 7.01item 9.01

  ProAssurance Q2 net loss $0.03/share; operating EPS $0.30; gross premiums up 13%

  Net loss $1.7M ($0.03 diluted); operating income $16.3M ($0.30 diluted).

• May 20, 2022, 7:59 PM ET other material materiality 0.65 neutral item 7.01item 9.01

  ProAssurance Q1 net loss $3.6M; non-GAAP operating EPS $0.14 improves from $0.04

  Gross premiums written rose 49% YoY to $335.6M, driven by NORCAL acquisition.

• February 25, 2022, 6:59 PM ET other material materiality 0.82 positive item 7.01item 9.01

  ProAssurance reports FY2021 gross premiums $960M, NORCAL acquisition closed, renewal rates up 8%

  NORCAL acquisition added ~$300M GPW and ~$1.6B investments; ProAssurance now #3 HCPL insurer in U.S.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 1.00 · Median 0.65 · Most common event earnings

9 positive 10 negative 31 neutral

source · PRA on sec.gov